CannBioRx Life Sciences (ATNFW) has had the highest return since August 1, 2025 by a US stock, returning 3,259.4%.
| ASSET | % RETURN |
|---|---|
CannBioRx Life Sciences (ATNFW) | 3,259.38% |
Cognition Therapeutics (CGTX) | 405.85% |
Advent Technologies (ADNWW) | 389.36% |
Equillium (EQ) | 375% |
Tharimmune (THAR) | 277.6% |
Ainos (AIMDW) | 254.62% |
BT Brands Inc Warrant (BTBDW) | 234.62% |
Bolt Projects (BSLK) | 230.4% |
Zepp Health (ZEPP) | 215.12% |
Atlantic International Corp Common Stock (ATLN) | 209.87% |
Reviva Pharmaceuticals (RVPHW) | 201% |
BioXcel Therapeutics (BTAI) | 200% |
Advent Technologies (ADN) | 172.04% |
GCM Grosvenor (GCMGW) | 167.23% |
Telos (TLS) | 162.8% |
Opendoor Technologies (OPEN) | 156.27% |
Matinas BioPharma (MTNB) | 150.59% |
Precigen (PGEN) | 150.3% |
X4 Pharmaceuticals (XFOR) | 148.1% |
Jyong Biotech Ltd Ordinary Shares (MENS) | 141.34% |
flyExclusive, Inc WT (FLYX.WT) | 128.57% |
I-Mab (IMAB) | 125.22% |
Aeries Technology (AERTW) | 125% |
Trinity Biotech (TRIB) | 124.29% |
Ondas (ONDS) | 119.02% |
